ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Accumulation of calcified material in the cardiovascular system affects millions of people, yet the detailed composition and architecture of the resulting lesions remain poorly understood. To get a close-up look, Molly M. Stevens, Sergio Bertazzo, and coworkers at Imperial College London used electron microscopy to analyze the lesions from people at different stages of calcific aortic valve disease (Nat. Mater., DOI: 10.1038/nmat3627). The researchers found nanoscale spherical particles of crystalline hydroxyapatite, a calcium phosphate mineral, in the lesions. Despite being chemically similar to bone, the nanoparticles are structurally different. Stevens and her coworkers were surprised to see the particles in the aortic valves of people who have no visible lesions but who have calcification elsewhere in the cardiovascular system. The researchers also found similar nanoparticles in calcific lesions caused by other cardiovascular diseases, including rheumatic fever and arteriosclerosis. They propose that the particles may be one of the first materials to form during calcification and are involved in the beginning stages of cardiovascular diseases, although they don’t yet know the role the particles play in mediating lesion formation.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter